Antisense Oligonucleotide (ASO) Therapeutics market is projected to grow at a CAGR of 14.5% by 2033: Visiongain
20. Oktober 2023 12:48 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033: Forecasts by Therapeutic Application (Neurological Disorders, Genetic Disorders,...
Antisense Oligonucleotide (ASO) Therapeutics Market Report Up to 2031, By Visiongain Research Inc
19. April 2022 10:00 ET
|
Visiongain Ltd
Visiongain has launched a new report Antisense Oligonucleotide (ASO) Therapeutics Market Report 2021-2031: Forecasts by Therapeutic Area (Genetic Disorders, Neurological Disorders, Oncological...